Big Pharma empire behind OxyContin now selling overdose cure

(Leila Coker | The Associated Press) This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication.

RELATED STORIES

$260 million deal averts 1st federal trial on opioid crisis

New study: Opioid crisis cost U.S. economy $631B over 4 years

State, local governments blast Purdue opioid settlement plan

Opioid talks at impasse; Purdue bankruptcy filing expected

Salt Lake County opioid town hall outlines challenges, successes in battling epidemic

MOST VIEWED

1

President Trump drastically shrinks 2 Utah national monuments — again

2

Utah just banned another Stephen King book from all public schools. Here’s what it’s about.

3

Moses was the ‘first capitalist’ and Cain the ‘first socialist.’ Thus saith this LDS influencer from the past

4

Sunday’s record high temp in SLC even affected air traffic

5

Brother of a key LDS apostle will go to prison for sending sexually explicit letters to Utah girl

Sponsored Story

Drunken Kitchen restaurant is now open to all ages.

Sponsored: This award-winning Taiwanese & Chinese restaurant with a bold American twist is now open to families.

By Claire Galofaro and Kristen Gelineau | The Associated Press